PetIQ Total Shareholders Equity 2011-2026 | PETQ

Annual Total Shareholders Equity PetIQ

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
223 M	212 M	255 M	246 M	328 M	321 M	105 M	41 M	46.3 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
328 M	41 M	198 M

Quarterly Total Shareholders Equity PetIQ

2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
239 M	-	215 M	267 M	261 M	255 M	263 M	270 M	257 M	246 M	246 M	246 M	246 M	328 M	328 M	328 M	328 M	321 M	321 M	321 M	321 M	105 M	105 M	105 M	105 M	41 M	41 M	-	-	46.3 M	-	-	-	48.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
328 M	41 M	222 M

Total Shareholders Equity of other stocks in the Drug manufacturers industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
Aerie Pharmaceuticals AERI	-17.3 M	-	-	$ 754 M	USA
Alimera Sciences ALIM	46.2 M	-	-	$ 142 M	USA
AcelRx Pharmaceuticals ACRX	8 M	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	-808 K	-	0.86 %	$ 117 M	USA
Agile Therapeutics AGRX	-16.3 M	-	10.11 %	$ 58.2 M	USA
Canopy Growth Corporation CGC	487 M	$ 1.05	-3.24 %	$ 113 M	Canada
Catalent CTLT	3.6 B	-	-	$ 11.5 B	USA
Avadel Pharmaceuticals plc AVDL	73.8 M	-	-	$ 2.06 B	France
Evolus EOLS	-23.1 M	$ 5.74	2.59 %	$ 370 M	USA
China Pharma Holdings CPHI	7.75 M	$ 0.54	-7.57 %	$ 9.43 M	China
DURECT Corporation DRRX	14.8 M	-	-	$ 50.1 M	USA
Cumberland Pharmaceuticals CPIX	22.9 M	$ 3.54	-3.54 %	$ 49.8 M	USA
Eagle Pharmaceuticals EGRX	234 M	-	-39.89 %	$ 27.7 M	USA
Calliditas Therapeutics AB (publ) CALT	1.01 B	-	-0.1 %	$ 2.03 B	Schweden
Endo International plc ENDP	-6.6 B	-	-	$ 28.9 M	Irlanda
HEXO Corp. HEXO	557 M	-	2.45 %	$ 38.1 M	Canada
Evoke Pharma EVOK	-2.58 M	-	-	$ 36.6 M	USA
Harrow Health HROW	52.4 M	$ 36.19	-7.73 %	$ 1.33 B	USA
Aurora Cannabis ACB	2.13 B	$ 3.51	-3.84 %	$ 86.3 M	Canada
Athenex ATNX	-6.51 M	-	-23.39 %	$ 1.76 M	USA
Jupiter Wellness JUPW	-2.17 M	-	-	$ 33.6 M	USA
Emergent BioSolutions EBS	649 M	$ 8.49	-3.19 %	$ 435 M	USA
Assertio Holdings ASRT	138 M	$ 11.96	-0.89 %	$ 850 M	USA
Bausch Health Companies BHC	-1.02 B	$ 5.56	-1.24 %	$ 2.03 B	Canada
Organogenesis Holdings ORGO	263 M	$ 2.89	0.52 %	$ 381 M	USA
Lannett Company LCI	-251 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	300 M	$ 1.46	4.68 %	$ 402 M	Canada
Neoleukin Therapeutics NLTX	186 M	-	-	$ 193 M	Canada
Sundial Growers SNDL	270 M	$ 1.52	-1.3 %	$ 3.37 M	Canada
Perrigo Company plc PRGO	2.94 B	$ 11.22	-4.06 %	$ 1.55 B	USA
TherapeuticsMD TXMD	29.3 M	$ 2.24	3.86 %	$ 23.4 M	USA
ProPhase Labs PRPH	63.6 M	-	-	$ 5.07 M	USA
Veru VERU	32.3 M	$ 2.53	0.8 %	$ 341 M	USA
Viatris VTRS	20.5 B	$ 14.58	-0.92 %	$ 17.5 B	USA
Radius Health RDUS	-252 M	-	-	$ 1.42 B	USA
cbdMD YCBD	1.96 M	$ 0.69	-10.34 %	$ 2.98 M	USA
Rockwell Medical RMTI	21.3 M	$ 0.88	-0.91 %	$ 20.5 M	USA
Pacira BioSciences PCRX	778 M	$ 22.78	-0.35 %	$ 1.05 B	USA
OptiNose OPTN	-86.6 M	-	-	$ 1.08 B	USA
PLx Pharma PLXP	35.7 M	-	-27.8 %	$ 2.56 M	USA
Recro Pharma REPH	58.7 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	85.4 M	$ 4.45	-6.81 %	$ 134 M	USA
SCYNEXIS SCYX	49.4 M	$ 0.76	-2.49 %	$ 37.9 M	USA
Solid Biosciences SLDB	137 M	$ 5.62	-8.55 %	$ 229 M	USA
Sonoma Pharmaceuticals SNOA	4.41 M	$ 2.66	-5.0 %	$ 3.3 M	USA
Tricida TCDA	218 K	-	-	$ 3.25 M	USA
Tilray TLRY	3.32 B	$ 7.07	-3.15 %	$ 4.37 B	Canada
Zynerba Pharmaceuticals ZYNE	46.2 M	-	-	$ 55.5 M	USA